The World Market for Orphan Drugs (2019-2023): Emergence of Combination Therapies & Novel Targets Spurs Market Growth

Ads

You May Also Like

US Department of Defense Reports Travelan Protects Against Shigella in Primates

Key Highlights: Travelan® pre-clinical shigellosis challenge studies in non-human primates (NHP) successfully completedTravelan® prevented ...

Soricimed Announces Changes to its Board of Directors

MONCTON, New Brunswick, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a ...